Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structural basis of HIV inhibition by L-nucleosides: Opportunities for drug development and repurpos

Journal Article · · Drug Discov. Today

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1900781
Journal Information:
Drug Discov. Today, Vol. 27, Issue (7)
Country of Publication:
United States
Language:
ENGLISH

References (70)

Viral reverse transcriptases journal April 2017
Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance journal April 2020
Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine journal February 2020
HIV-1 reverse transcriptase and antiviral drug resistance. Part 1 journal April 2013
HIV-1 reverse transcriptase and antiviral drug resistance. Part 2 journal April 2013
Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition journal January 2009
Large-Scale Production and Structural and Biophysical Characterizations of the Human Hepatitis B Virus Polymerase journal March 2014
Molecular Modeling and Biochemical Characterization Reveal the Mechanism of Hepatitis B Virus Polymerase Resistance to Lamivudine (3TC) and Emtricitabine (FTC) journal May 2001
Discovery and Development of the Anti-Human Immunodeficiency Virus Drug, Emtricitabine (Emtriva, FTC) journal October 2016
Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes journal March 1992
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. journal November 1992
Post-Catalytic Complexes with Emtricitabine or Stavudine and HIV-1 Reverse Transcriptase Reveal New Mechanistic Insights for Nucleotide Incorporation and Drug Resistance journal October 2020
Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine journal August 2019
Elucidating molecular interactions of L-nucleotides with HIV-1 reverse transcriptase and mechanism of M184V-caused drug resistance journal December 2019
King of the pills journal May 2015
Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance journal October 2014
The Enantioselectivity of Enzymes Involved in Current Antiviral Therapy Using Nucleoside Analogues: A New Strategy? journal June 2000
The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold journal June 2018
Structural basis for the D-stereoselectivity of human DNA polymerase β journal April 2017
Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γ journal June 2015
Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta -branched amino acids journal August 1999
Interactions of enantiomers of 2′,3′-didehydro-2′,3′-dideoxy-fluorocytidine with wild type and M184V mutant HIV-1 reverse transcriptase journal December 2002
Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance journal October 2009
The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance journal January 2010
Nucleoside Analog Resistance Caused by Insertions in the Fingers of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Involves ATP-Mediated Excision journal September 2002
Thymidine Analogue Resistance Suppression by V75I of HIV-1 Reverse Transcriptase journal November 2009
HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir journal January 2018
Active-site deformation in the structure of HIV-1 RT with HBV-associated septuple amino acid substitutions rationalizes the differential susceptibility of HIV-1 and HBV against 4ʹ-modified nucleoside RT inhibitors journal February 2019
Conformational States of HIV-1 Reverse Transcriptase for Nucleotide Incorporation vs Pyrophosphorolysis—Binding of Foscarnet journal June 2016
Structure of HIV-1 reverse transcriptase bound to a novel 38-mer hairpin template-primer DNA aptamer: Structure of RT Bound to 38-Mer DNA Aptamer journal September 2015
Structural Insights into HIV Reverse Transcriptase Mutations Q151M and Q151M Complex That Confer Multinucleoside Drug Resistance journal June 2017
Coupling Ribose Selection to Fidelity of DNA Synthesis journal June 2000
Conferring RNA polymerase Activity to a DNA polymerase: A single residue in reverse transcriptase controls substrate selection journal January 1997
Stereospecificity of human DNA polymerases α,β,γ,§ and ɛ, HIV-reverse transcriptase, HSV- DNA polymerase, calf thymus terminal transferase andEscherichia coliDNA polymerase I in recognizing D- and L-thymidine 5′-triphosphate as substrate journal January 1995
Molecular basis for the enantioselectivity of HIV-1 reverse transcriptase: role of the 3'-hydroxyl group of the L-(beta)-ribose in chiral discrimination between D- and L-enantiomers of deoxy- and dideoxy-nucleoside triphosphate analogs journal February 1999
Stereoisomers of Deoxynucleoside 5′-Triphosphates as Substrates for Template-dependent and -independent DNA Polymerases journal April 1997
Chiral Discrimination of Enantiomeric 2′-Deoxythymidine 5′-Triphosphate by HIV-1 Reverse Transcriptase and Eukaryotic DNA Polymerases journal April 1994
Integrative structural biology studies of HIV-1 reverse transcriptase binding to a high-affinity DNA aptamer journal January 2020
Nucleotide-dependent conformational change governs specificity and analog discrimination by HIV reverse transcriptase journal April 2010
Structural basis of HIV inhibition by translocation-defective RT inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) journal August 2016
The High Genetic Barrier of EFdA/MK-8591 Stems from Strong Interactions with the Active Site of Drug-Resistant HIV-1 Reverse Transcriptase journal October 2018
The Nucleoside Analogs 4′C-Methyl Thymidine and 4′C-Ethyl Thymidine Block DNA Synthesis by Wild-type HIV-1 RT and Excision Proficient NRTI Resistant RT Variants journal August 2007
Synthesis of new 2′-deoxy-2′-fluoro-4′-azido nucleoside analogues as potent anti-HIV agents journal September 2011
Effects of β-l-3′-azido-3′-deoxythymidine 5′-triphosphate on host and viral DNA polymerases journal August 2000
Antiviral l-Nucleosides Specific for Hepatitis B Virus Infection journal January 2001
Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3′-azido-2′,3′-dideoxypurine nucleosides journal September 2011
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency journal May 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms journal December 2020
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A journal February 2021
Inhibiting DNA Polymerases as a Therapeutic Intervention against Cancer journal November 2017
Pre-Steady-State Kinetic Analysis of the Incorporation of Anti-HIV Nucleotide Analogs Catalyzed by Human X- and Y-Family DNA Polymerases journal November 2010
Exploiting the Nucleotide Substrate Specificity of Repair DNA Polymerases To Develop Novel Anticancer Agents journal September 2011
Structural and kinetic insights into binding and incorporation of L-nucleotide analogs by a Y-family DNA polymerase journal August 2014
Innate immune driven evolution via immunostimulatory RNA: Viruses that mimic hosts, tumors that mimic viruses journal February 2017
Initial sequencing and analysis of the human genome journal February 2001
The Influence of LINE-1 and SINE Retrotransposons on Mammalian Genomes journal April 2015
Silent pericentromeric repeats speak out journal November 2015
Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer journal November 2015
Phase II study of lamivudine in p53 mutant metastatic colorectal cancer (mCRC). journal February 2020
Telomerase and retrotransposons: Reverse transcriptases that shaped genomes journal December 2011
Measuring and interpreting transposable element expression journal June 2020
Synthesis and Characterization of Specific Reverse Transcriptase Inhibitors for Mammalian LINE-1 Retrotransposons journal August 2019
Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging journal January 2013
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development journal September 2020
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity journal November 2014
Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration journal February 2021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degeneration journal April 2021
Lamivudine InhibitsAluRNA-induced Retinal Pigment Epithelium Degeneration via Anti-inflammatory and Anti-senescence Activities journal July 2020
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19 journal July 2020
Compatibility and Fidelity of Mirror-Image Thymidine in Transcription Events by T7 RNA Polymerase journal September 2020